Unity Biotechnology, Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Unity Biotechnology, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Unity Biotechnology, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $1.2M, a 29.6% decline year-over-year.
  • Unity Biotechnology, Inc. annual Operating Lease, Payments for 2023 was $4.81M, a 23.4% decline from 2022.
  • Unity Biotechnology, Inc. annual Operating Lease, Payments for 2022 was $6.28M, a 5.56% decline from 2021.
  • Unity Biotechnology, Inc. annual Operating Lease, Payments for 2021 was $6.65M, a 14.8% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.81M -$1.47M -23.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 $6.28M -$370K -5.56% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 $6.65M +$856K +14.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-04-15
2020 $5.8M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.